CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,515,000 | -11.3% | 132,571 | +0.6% | 0.15% | -20.7% |
| Q4 2021 | $5,092,000 | +22.0% | 131,771 | +70.5% | 0.18% | +44.9% |
| Q3 2021 | $4,173,000 | +18.8% | 77,285 | -26.4% | 0.13% | +16.5% |
| Q2 2021 | $3,513,000 | +4.2% | 105,056 | -35.8% | 0.11% | +13.5% |
| Q1 2021 | $3,370,000 | +57.6% | 163,615 | +13.5% | 0.10% | -12.7% |
| Q3 2020 | $2,138,000 | -34.2% | 144,200 | -42.3% | 0.11% | -64.9% |
| Q2 2020 | $3,251,000 | – | 250,100 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |